Tourmaline Bio's market cap is currently $317.20M. The company's EPS TTM is $-2.821; its P/E ratio is ―; Tourmaline Bio is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $-0.86. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -33.00K	$ -6.00K	$ -623.00K	$ -447.00K	$ -379.00K
Operating Income	$ -45.41M	$ -19.70M	$ -904.00	$ -22.68M	$ -18.38M
EBITDA	$ -45.38M	$ -19.70M	$ -46.88M	$ -22.24M	$ -17.78M
Net Income	$ -42.12M	$ -19.70M	$ -904.00	$ -22.71M	$ -18.16M
Balance Sheet
Cash & Short-Term Investments	$ 202.95M	$ 8.26M	$ 150.00K	$ 149.49M	$ 38.98M
Total Assets	$ 210.29M	$ 9.10M	$ 150.00K	$ 152.78M	$ 41.94M
Total Debt	$ 415.00K	$ 504.00K	$ 150.00K	$ 0.00	$ 0.00
Net Debt	$ -140.31M	$ -7.75M	$ 0.00	$ -17.59M	$ -38.98M
Total Liabilities	$ 5.25M	$ 28.83M	$ 376.00K	$ 4.77M	$ 2.35M
Stockholders' Equity	$ 205.04M	$ -19.73M	$ -226.00K	$ 148.00M	$ 39.59M
Cash Flow
Free Cash Flow	$ -28.14M	$ -11.53M	$ -42.42M	$ -20.50M	$ -18.22M
Operating Cash Flow	$ -28.08M	$ -6.46M	$ -39.99M	$ -19.21M	$ -17.66M
Investing Cash Flow	$ 3.84M	$ -5.07M	$ -96.39M	$ -133.30M	$ -562.00K
Financing Cash Flow	$ 156.72M	$ 19.85M	$ 137.40M	$ 131.12M	$ 36.20M

Currency in USD

Tourmaline Bio Earnings and Revenue History

Income Statement >

Tourmaline Bio Debt to Assets

Balance Sheet >

Tourmaline Bio Cash Flow

Cash Flow >

Tourmaline Bio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing